Long-term hematologic reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10% dimethylsulfoxide at -80°C in a mechanical freezer

Haematologica

Volumn 92, Issue 7, 2007, Pages 986-989

  Galmes, Antonio ^a,b   Gutiérrez, Antonio ^a   Sampol, Antonia ^a,b   Canaro, Mariana ^a   Morey, Miguel ^a   Iglesias, Julio ^a   Matamoros, Nuria ^a   Duran, María Antonia ^a   Novo, Andrés ^a   Bea, María Dolores ^a   Galán, Pilar ^c   Balansat, Josep ^d   Martínez, Jordi ^a   Bargay, Joan ^a   Besalduch, Joan ^a,b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Hematology Service   (Spain)

^c Hematology Service   (Spain)

^d Hematology Service   (Spain)

Author keywords

Autologous stem cell transplantation; Cryopreservation; DMSO; Mechanical freezer

Indexed keywords

CD34 ANTIGEN; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CELL COUNT; CHILD; CONTROLLED STUDY; CONVALESCENCE; CRYOPRESERVATION; ENGRAFTMENT; FEASIBILITY STUDY; FEMALE; FREEZING; HUMAN; HUMAN CELL; INFUSION; MALE; STEM CELL MOBILIZATION; TECHNIQUE; THAWING; THROMBOCYTE FUNCTION; TOXICITY; AUTOTRANSPLANTATION; BLOOD STORAGE; CYTOLOGY; DRUG EFFECT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; METHODOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

BLOOD PRESERVATION; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 34548809074     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11060     Document Type: Article

References (20)

1. Elliott C, McCarthy D. A survey of methods of processing and storage of bone marrow and blood stem cells in the EBMT. Bone Marrow Transplant 1994;14:419-23.
2. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6:
3. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
4. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18:4705-8.
5. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.
6. Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003;325:349-62.
7. Galmes A, Besalduch J, Bargay J, Matamores N, Morey M, Novo A, et al. A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma 1995;17:181-4.
8. Galmes A, Besalduch J, Bargay J, Matamoros N, Duran MA, Morey M, et al. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing. Transfusion 1996;36:794-7.
9. Galmes A, Besalduch J, Bargay J, Novo A, Morey M, Guerra JM, et al. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999;39:70-3.
10. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
11. McQuaker IG, Hunter AE, Pacey S, Haynes AP, Iqbal A, Russell NH. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997;15:451-7.
12. Sampol Mayol A, Besalduch Vital J, Galmes Llodra A, Bargay Lleonart J, Matamoros Flori N, Morey Sureda M, et al. CD34+ cell dose and CD33-subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation. Haematologica 1998;83:489-95.
13. Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, et al. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003;31:1043-51.
14. Montanari M, Capelli D, Poloni A, Massidda D, Brunori M, Spitaleri L, et al. Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at -80 degrees C. Transfusion 2003;43:42-9.
15. Lakota J, Fuchsberger P. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 1996;18:262-3.
16. Makino S, Harada M, Akashi K, Taniguchi S, Shibuya T, Inaba S, et al. A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant 1991;8:239-44.
17. Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987;70:974-8.
18. Rosenfeld CS, Gremba C, Shadduck RK, Zeigler ZR, Nemunaitis J. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Exp Hematol 1994;22:290-4.
19. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005;36:601-3.
20. Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995; 346:137-40.